Advertisement

Reactions Weekly

, Volume 1719, Issue 1, pp 210–210 | Cite as

Ruxolitinib

Various toxicities: 6 case reports
Case report
  • 6 Downloads

Reference

  1. Lancman G, et al. Ruxolitinib for steroid-refractory graft-versus-host disease: A case series. Hematological Oncology 36: 611-613, No. 3, 25 Mar 2018. Available from: URL: http://doi.org/10.1002/hon.2505 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations